Serveur d'exploration sur les peptides biopesticides - Exploration (Accueil)

Index « Mesh.i » - entrée « Severity of Illness Index »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Severe Dengue < Severity of Illness Index < Sevoflurane  Facettes :

List of bibliographic references indexed by Severity of Illness Index

Number of relevant bibliographic references: 85.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000011 (2020) Hao Zeng [République populaire de Chine] ; Dongfang Wang [République populaire de Chine] ; Jingmin Nie [République populaire de Chine] ; Haoyu Liang [République populaire de Chine] ; Jiang Gu [République populaire de Chine] ; Anne Zhao [République populaire de Chine] ; Lixin Xu [République populaire de Chine] ; Chunhui Lang [République populaire de Chine] ; Xiaoping Cui [République populaire de Chine] ; Xiaolan Guo [République populaire de Chine] ; Changlong Zhou [République populaire de Chine] ; Haibo Li [République populaire de Chine] ; Bin Guo [République populaire de Chine] ; Jinyong Zhang [République populaire de Chine] ; Qiang Wang [République populaire de Chine] ; Li Fang [République populaire de Chine] ; Wen Liu [République populaire de Chine] ; Yishan Huang [République populaire de Chine] ; Wei Mao [Oman] ; Yaokai Chen [Oman] ; Quanming Zou [Oman]The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series.
000020 (2020) Emilie Sbidian [France] ; Anna Chaimani [France] ; Sivem Afach [France] ; Liz Doney [Royaume-Uni] ; Corinna Dressler ; Camille Hua ; Canelle Mazaud ; Céline Phan [France] ; Carolyn Hughes [Royaume-Uni] ; Dru Riddle [États-Unis] ; Luigi Naldi ; Ignacio Garcia-Doval ; Laurence Le Cleach [France]Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
000070 (2020) Raymond Chang [États-Unis] ; Tzi Bun Ng [Hong Kong] ; Wei-Zen Sun [Taïwan]Lactoferrin as potential preventative and adjunct treatment for COVID-19.
000096 (2020) Mingliang Qiu ; Zhongbo Xu ; Wenjuan Gao ; Meizhen Xiong ; Xianhua Wen ; Weina Zhu ; Xu Zhou ; Minfeng Yu [République populaire de Chine]Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials.
000116 (2020) Dimitrios C. Mastellos [Grèce] ; Bruno G P. Pires Da Silva [Brésil] ; Benedito A L. Fonseca [Brésil] ; Natasha P. Fonseca [Brésil] ; Maria Auxiliadora-Martins [Brésil] ; Sara Mastaglio [Italie] ; Annalisa Ruggeri [Italie] ; Marina Sironi [Italie] ; Peter Radermacher [Allemagne] ; Akrivi Chrysanthopoulou [Grèce] ; Panagiotis Skendros [Grèce] ; Konstantinos Ritis [Grèce] ; Ilenia Manfra [Italie] ; Simona Iacobelli [Italie] ; Markus Huber-Lang [Allemagne] ; Bo Nilsson [Suède] ; Despina Yancopoulou [Grèce] ; E Sander Connolly [États-Unis] ; Cecilia Garlanda [Italie] ; Fabio Ciceri [Italie] ; Antonio M. Risitano [Italie] ; Rodrigo T. Calado [Brésil] ; John D. Lambris [États-Unis]Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.
000196 (2019) S. D'Adamio [Italie] ; D. Silvaggio [Italie] ; P. Lombardo [Italie] ; L. Bianchi [Italie] ; M. Talamonti [Italie] ; M. Galluzzo [Italie]The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis.
000229 (2019) Tooba Ghazanfari [Iran] ; Hassan Ghasemi [Iran] ; Roya Yaraee [Iran] ; Mahmoud Mahmoudi [Iran] ; Mohammad Ali Javadi [Iran] ; Mohammad Reza Soroush [Iran] ; Soghrat Faghihzadeh [Iran] ; Ali Mohammad Mohseni Majd [Iran] ; Raheleh Shakeri [Iran] ; Mahmoud Babaei [Iran] ; Fatemeh Heidary [Iran] ; Zuhair Mohammad Hassan [Iran]Tear and serum interleukin-8 and serum CX3CL1, CCL2 and CCL5 in sulfur mustard eye-exposed patients.
000467 (2019) Yidian Dong [République populaire de Chine] ; Ping Li [République populaire de Chine] ; Tingshuang Xu [République populaire de Chine] ; Liqi Bi [République populaire de Chine]Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis.
000474 (2019) Mara Huffenbaecher Giavina-Bianchi [Brésil] ; Pedro Giavina-Bianchi [Brésil] ; Luiz Vicente Rizzo [Brésil]Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report.
000561 (2019) Alida Benfante [Italie] ; Stefania Principe [Italie] ; Salvatore Battaglia [Italie] ; Nicola Scichilone [Italie]Are biological drugs effective and safe in older severe asthmatics?
000631 (2018) Jorge Sánchez [Colombie] ; Josefina Zakzuk [Colombie] ; Ricardo Cardona [Colombie]Evaluation of a Guidelines-Based Approach to the Treatment of Chronic Spontaneous Urticaria.
000702 (2018) Fabio Massimo Perrotta [Italie] ; Fulvia Ceccarelli [Italie] ; Cristiana Barbati [Italie] ; Tania Colasanti [Italie] ; Antonia De Socio [Italie] ; Silvia Scriffignano [Italie] ; Cristiano Alessandri [Italie] ; Ennio Lubrano [Italie]Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study.
000709 (2018) Wang Xing-Rong ; Xu Sheng-Qian ; Liu Wen ; Qi Shan ; Pan Fa-Ming [République populaire de Chine] ; Xu Jian-HuaRole of TNFRSF1A and TNFRSF1B polymorphisms in susceptibility, severity, and therapeutic efficacy of etanercept in human leukocyte antigen-B27-positive Chinese Han patients with ankylosing spondylitis.
000720 (2018) Corrado Pelaia [Italie] ; Maria Teresa Busceti [Italie] ; Sabina Solinas [Italie] ; Rosa Terracciano [Italie] ; Girolamo Pelaia [Italie]Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study.
000836 (2018) Leena Yr V Inen [Finlande] ; Anna Maria Heikkinen [Finlande] ; Antti Kuuliala [Finlande] ; Kirsi Ahola [Finlande] ; Riitta Koivuniemi [Finlande] ; Leena Laasonen [Finlande] ; Eeva Moilanen [Finlande] ; Mari H M L Inen [Finlande] ; Taina Tervahartiala [Finlande] ; Jukka H. Meurman [Finlande] ; Marjatta Leirisalo-Repo [Finlande] ; Timo Sorsa [Finlande, Suède]Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status.
000972 (2018) Kentaro Inui ; Tatsuya Koike ; Masahiro Tada ; Yuko Sugioka ; Tadashi Okano ; Kenji Mamoto ; Akira Sakawa ; Kenzo Fukushima [Japon] ; Hiroaki NakamuraClinical and radiologic analysis of on-demand use of etanercept for disease flares in patients with rheumatoid arthritis for 2 years: The RESUME study: A case-control study.
000B06 (2017) A B Gottlieb [États-Unis] ; J-P Lacour [France] ; N. Korman [États-Unis] ; S. Wilhelm [Allemagne] ; Y. Dutronc [France] ; A. Schacht [Allemagne] ; J. Erickson [États-Unis] ; L. Zhang [États-Unis] ; L. Mallbris [États-Unis] ; S. Gerdes [Allemagne]Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies.
000B13 (2017) Selma Atalay [Pays-Bas] ; Juul M P A. Van Den Reek [Pays-Bas] ; Lieke J. Van Vugt [Pays-Bas] ; Marisol E. Otero [Pays-Bas] ; Peter C M. Van De Kerkhof [Pays-Bas] ; Alfons A. Den Broeder [Pays-Bas] ; Wietske Kievit [Pays-Bas] ; Elke M G J. De Jong [Pays-Bas]Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial.
000B58 (2017) Andrew Keat [Royaume-Uni] ; Alexander N. Bennett [Royaume-Uni] ; Karl Gaffney [Royaume-Uni] ; Helena Marzo-Ortega [Royaume-Uni] ; Raj Sengupta [Royaume-Uni] ; Tamara Everiss [Royaume-Uni]Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?
000B76 (2017) Tsai-Ling Liao [Taïwan] ; Yi-Ming Chen [Taïwan] ; Hung-Jen Liu [Taïwan] ; Der-Yuan Chen [Taïwan]Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
000C17 (2017) Emily B. Schroeder [États-Unis] ; Stan Xu [États-Unis] ; Glenn K. Goodrich [États-Unis] ; Gregory A. Nichols [États-Unis] ; Patrick J. O'Connor [États-Unis] ; John F. Steiner [États-Unis]Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: Development and external validation of a prediction model.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/BiopestPeptidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Severity of Illness Index" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Severity of Illness Index" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    BiopestPeptidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Severity of Illness Index
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 19:22:35 2020. Site generation: Thu Nov 19 19:33:26 2020